Personal profile
Headline
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Performance of Treatment Response Assessment at Day 7 by Baseline Acute Graft-versus-Host Disease Severity
Louloudis, I. E., Chen, Y. B., Spyrou, N., Alousi, A., Katsivelos, N., Ayuk, F., Weber, D., Hogan, W. J., Etra, A. M., Qayed, M., Aguayo-Hiraldo, P., Akahoshi, Y., Malki, M. M. A., Bolaños-Meade, J., Chanswangphuwana, C., Diniz, M., Eder, M., Hexner, E., Kitko, C. L. & Kraus, S. & 14 others, , Jan 2026, In: Transplantation and Cellular Therapy. 32, 1, p. 63.e1-63.e11Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Ibrutinib for therapy of steroid-refractory chronic graft-versus-host disease: a multicenter real-world analysis
Pidala, J., Kim, J., Kalos, D., Cutler, C., DeFilipp, Z., Flowers, M. E. D., Hamilton, B. K., Chin, K. K., Rotta, M., El Jurdi, N., Hamadani, M., Ahmed, G., Kitko, C., Ponce, D., Sung, A., Tang, H., Farhadfar, N., Nemecek, E., Pusic, I. & Qayed, M. & 4 others, , 11 Mar 2025, In: Blood advances. 9, 5, p. 1040-1048 9 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Rare Autoimmune Pancytopenia Due to Graves Disease
Wang, A. W., Mahajan, G., Etra, A. & Saul, S. R., 1 Jun 2025, In: JCEM Case Reports. 3, 6, luaf032.Research output: Contribution to journal › Article › peer-review
Open Access -
Refinement of day 28 treatment response criteria for acute GVHD: a collaboration study of the JSTCT and MAGIC
on behalf of the JSTCT and MAGIC, 23 Sep 2025, In: Blood advances. 9, 18, p. 4640-4653 14 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Remestemcel-L-rknd (Ryoncil): the first approved cellular therapy for steroid-refractory acute GVHD
Etra, A., Ferrara, J. L. M. & Levine, J. E., 16 Oct 2025, In: Blood. 146, 16, p. 1897-1901 5 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations
Press/Media
-
New Graft-Versus-Host Disease Study Findings Have Been Reported from Icahn School of Medicine at Mount Sinai (The MAGIC Composite Response: A Novel Endpoint Integrating Clinical and Biomarker Parameters for Acute GVHD)
Etra, A. & Akahoshi, Y.
28/08/25
1 item of Media coverage
Press/Media
-
Studies from Icahn School of Medicine at Mount Sinai Add New Findings in the Area of Biomarkers (Serial Clinical and Biomarker Monitoring During Graft-versus-host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-low Risk ...)
Levine, J., Etra, A., Akahoshi, Y. & Ferrara, J.
24/02/25
1 item of Media coverage
Press/Media
-
Researcher at Icahn School of Medicine at Mount Sinai Releases New Study Findings on Graft-Versus-Host Disease (Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD)
Levine, J., Etra, A., Akahoshi, Y. & Ferrara, J.
3/09/24
1 item of Media coverage
Press/Media
-
New Study Findings from Icahn School of Medicine at Mount Sinai Illuminate Research in Biomarkers (Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD)
Levine, J., Etra, A., Akahoshi, Y. & Ferrara, J.
22/07/24
1 item of Media coverage
Press/Media
-
Researchers from Icahn School of Medicine at Mount Sinai Report New Studies and Findings in the Area of Biomarkers (The Utility of Biomarkers In Acute Gvhd Prognostication)
Levine, J., Etra, A., Akahoshi, Y. & Ferrara, J.
19/03/24
1 item of Media coverage
Press/Media